IM Cannabis Corp. (IMCC)
NCM · Drug Manufacturers - Specialty & Generic
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Peers in Drug Manufacturers - Specialty & Generic
All in industry →Takeda Pharmaceutical Company Limited
Zoetis Inc.
Haleon plc
Teva Pharmaceutical Industries Limited
United Therapeutics Corporation
Viatris Inc.
Regencell Bioscience Holdings Limited
Neurocrine Biosciences, Inc.
Elanco Animal Health Incorporated
Dr. Reddy's Laboratories Limited
Recent press releases
March 2026
IM Cannabis Corp. — 20-F Filing
# 🧾 What This Document Is This is IM Cannabis Corp.'s **annual report (Form 20-F)** for the year ended December 31, 2025. It's a comprehensive filing required by the U.S. SEC for foreign companies listed on American exchanges. Think of it as the company's official "year in review" and health check-
SEC filings
All filings →Insider trades
All insider trades →IM Cannabis Corp. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at IM Cannabis Corp.
All people →No officers or directors have been indexed for IM Cannabis Corp..